Searched for
NEUROCRINE SOLENO DEAL
Soleno withdraws EU rare disease drug application ahead of Neurocrine takeoverSoleno Therapeutics has withdrawn its European drug application. This decision stems from its acquirer, Neurocrine Biosciences, prioritizin...- US stocks today: US stocks end higher as investors parse US-Iran negotiations, threatsAs eyes turn towards international events, Indian investors are paying close attention. US stock markets experienced a rally, fueled by hop...
- Soleno shares jump 33% as Neurocrine expands into metabolic diseases with $2.9 billion buyoutNeurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, mark...
- Stock futures market today: Bitcoin, Cryptocurrency-linked firms, Soleno Therapeutics stocks to watch out on Monday as S&P 500, Nasdaq, Dow set for mixed startStock Market futures today: Bitcoin prices jumped on Monday as U.S.-listed shares of cryptocurrency-linked firms rose, with Coinbase and St...
- Why are US stock market futures up today, and will Dow, S&P 500 and Nasdaq stay in green or turn red again? Wall Street futures rise, US stocks to watch out for, analysts insights, market outlookWhy are US stock market futures up today, and will Dow, S&P 500 and Nasdaq stay in green or turn red again? US stock futures moved higher a...
Load More